NCT05152628View on ClinicalTrials.gov

A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 11, 2022

Primary Completion Date

March 6, 2024

Study Completion Date

March 6, 2024

Conditions
Liver TransplantationKidney Transplantation
Interventions
DRUG

Tacrolimus granules

Oral

DRUG

Tacrolimus granules

Oral

Trial Locations (4)

Unknown

Site CN86003, Beijing

Site CN86002, Guangzhou

Site CN86001, Shanghai

Site CN86004, Wuhan

All Listed Sponsors
lead

Astellas Pharma China, Inc.

INDUSTRY

NCT05152628 - A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients | Biotech Hunter | Biotech Hunter